By Turna Ray

NEW YORK (GenomeWeb News) – How broad can the claims in a gene patent be without impeding research and still be of financial value to the patent holder? While a US District Court judge in a pending high-profile anti-gene patenting case is currently mulling over the answer to this very question, researchers from Duke University used bioinformatics to estimate the reach of a claim from one of Myriad Genetics' patents on the BRCA1 gene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.